This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fish, D. C. Articles by Lincoln, R. E. Search for Related Content PubMed PubMed Citation Articles by Fish, D. C. Articles by Lincoln, R. E.

 Previous Article  |  Next Article 

J Bacteriol. 1968 March; 95(3): 907-918
Copyright © 1968 American Society for Microbiology. All Rights Reserved.

Purification and Properties of In Vitro–produced Anthrax Toxin Components

¹ Department of the Army, Fort Detrick, Frederick, Maryland 21701

ABSTRACT

The three components of the toxin of Bacillus anthracis, edema factor (EF), protective antigen (PA), and lethal factor (LF), were purified 197-, 156-, and 1,025- fold, with 38, 78, and 11% recovery, respectively. Each purified component was serologically active, distinct, and free from the other components. The purified EF produced edema when mixed with PA, and the purified PA was an active immunogen. The components did not appear to be simple proteins by spectrophotometric analysis. As they were purified, the pH range in which they were most stable narrowed, centering between pH 7.4 and 7.8. Heat readily destroyed the biological activity of the components but not their serological activity. The rat lethality test showed that, with a constant amount of LF and an increasing amount of PA, the time to death reached a minimum and then was extended. When an increasing amount of LF was added to a constant amount of PA, the time to death became shorter as more LF was added. The biological, immunological, and serological properties of the components were shown to vary independently with storage and extent of purification so that serological activity was not always directly correlated with biological activity. Evidence is presented that the components can exist in different molecular configurations or as aggregates, and that this property is influenced by the state of component purity and by the environment.

This article has been cited by other articles:

• Reuveny, S., White, M. D., Adar, Y. Y., Kafri, Y., Altboum, Z., Gozes, Y., Kobiler, D., Shafferman, A., Velan, B. (2001). Search for Correlates of Protective Immunity Conferred by Anthrax Vaccine. Infect. Immun. 69: 2888-2893 [Abstract] [Full Text]  
• Cohen, S., Mendelson, I., Altboum, Z., Kobiler, D., Elhanany, E., Bino, T., Leitner, M., Inbar, I., Rosenberg, H., Gozes, Y., Barak, R., Fisher, M., Kronman, C., Velan, B., Shafferman, A. (2000). Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax. Infect. Immun. 68: 4549-4558 [Abstract] [Full Text]  
• Brossier, F., Sirard, J.-C., Guidi-Rontani, C., Duflot, E., Mock, M. (1999). Functional Analysis of the Carboxy-Terminal Domain of Bacillus anthracis Protective Antigen. Infect. Immun. 67: 964-967 [Abstract] [Full Text]